CryoLife Inc. (CRY) Issues FY13 Earnings Guidance
CryoLife Inc. (NYSE:CRY) issued an update on its FY13 earnings guidance on Tuesday morning. The company provided EPS guidance of $0.29-0.31 for the period, compared to the Thomson Reuters consensus EPS estimate of $0.25, AmericanBankingNews.com reports. The company issued revenue guidance of $139-141 million, compared to the consensus revenue estimate of $139.61 million.
Shares of CryoLife Inc. (NYSE:CRY) opened at 8.13 on Tuesday. CryoLife Inc. has a 1-year low of $5.52 and a 1-year high of $7.80. The stock’s 50-day moving average is $6.62 and its 200-day moving average is $6.34. The company has a market cap of $224.5 million and a price-to-earnings ratio of 30.11.
CryoLife (NYSE:CRY) last released its earnings data on Tuesday, October 29th. The company reported $0.12 earnings per share for the quarter, beating the analysts’ consensus estimate of $0.05 by $0.07. The company had revenue of $36.30 million for the quarter, compared to the consensus estimate of $35.51 million. During the same quarter last year, the company posted $0.08 earnings per share. CryoLife’s revenue was up 8.7% compared to the same quarter last year. Analysts expect that CryoLife Inc. will post $0.36 EPS for the current fiscal year.
CryoLife, Inc (NYSE:CRY) is a biological medical device company.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.